Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS - a Randomised, Placebo-controlled, Double-blind Trial

Trial Profile

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS - a Randomised, Placebo-controlled, Double-blind Trial

Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Aug 2018

At a glance

  • Drugs Solnatide (Primary)
  • Indications Acute lung injury; Adult respiratory distress syndrome; Pulmonary oedema
  • Focus Adverse reactions
  • Sponsors APEPTICO Forschung und Entwicklung
  • Most Recent Events

    • 03 Mar 2018 Status changed from planning to recruiting.
    • 16 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top